Literature DB >> 23060440

Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2.

Yongshu Zhang1, Gabriel Eades, Yuan Yao, Qinglin Li, Qun Zhou.   

Abstract

Several reports have indicated that miR-140, a possible tumor suppressor microRNA (miR), is down-regulated in breast tumors compared with normal breast tissues. However, the role of miR-140 in breast tumorigenesis is unclear. We initiated studies that examined estrogen receptor α (ERα) signaling in the tissue-specific regulation of miR-140 in breast cancer. We found that estrogen stimulation of ERα-positive breast cancer cells resulted in decreased miR-140 expression. We performed promoter analyses and examined predicted ERα binding elements in the miR-140 promoter using luciferase constructs of a miR-140 promoter deletion series. Our studies revealed that ERα binds to one specific estrogen response element flanking the miR-140 promoter and consequently suppresses miR-140 transcription. We found that the stem cell self-renewal regulator SOX2 is a novel target of miR-140, and that this miR-140/SOX2 pathway critically regulates breast tumor-initiating cell survival, providing a new link between ERα signaling and breast cancer stem cell maintenance.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23060440      PMCID: PMC3510847          DOI: 10.1074/jbc.M112.404871

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Cancer stem cells and self-renewal.

Authors:  Catherine Adell O'Brien; Antonija Kreso; Catriona H M Jamieson
Journal:  Clin Cancer Res       Date:  2010-06-08       Impact factor: 12.531

2.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

Authors:  Gabriela Dontu; Wissam M Abdallah; Jessica M Foley; Kyle W Jackson; Michael F Clarke; Mari J Kawamura; Max S Wicha
Journal:  Genes Dev       Date:  2003-05-15       Impact factor: 11.361

3.  Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.

Authors:  Christine M Fillmore; Piyush B Gupta; Jenny A Rudnick; Silvia Caballero; Patricia J Keller; Eric S Lander; Charlotte Kuperwasser
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-22       Impact factor: 11.205

4.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

Review 5.  Estrogen and progesterone in normal mammary gland development and in cancer.

Authors:  John Stingl
Journal:  Horm Cancer       Date:  2010-12-16       Impact factor: 3.869

Review 6.  Breast cancer stem cells: treatment resistance and therapeutic opportunities.

Authors:  Fares Al-Ejeh; Chanel E Smart; Brian J Morrison; Georgia Chenevix-Trench; J Alejandro López; Sunil R Lakhani; Michael P Brown; Kum Kum Khanna
Journal:  Carcinogenesis       Date:  2011-02-10       Impact factor: 4.944

7.  MiR-140 is co-expressed with Wwp2-C transcript and activated by Sox9 to target Sp1 in maintaining the chondrocyte proliferation.

Authors:  Jun Yang; Shengying Qin; Chengqing Yi; Gang Ma; Huang Zhu; Wenrong Zhou; Yuyu Xiong; Xuming Zhu; Yujiong Wang; Lin He; Xizhi Guo
Journal:  FEBS Lett       Date:  2011-08-26       Impact factor: 4.124

8.  Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.

Authors:  Claudia Lengerke; Tanja Fehm; Ralf Kurth; Hans Neubauer; Veit Scheble; Friederike Müller; Friederike Schneider; Karen Petersen; Diethelm Wallwiener; Lothar Kanz; Falko Fend; Sven Perner; Petra M Bareiss; Annette Staebler
Journal:  BMC Cancer       Date:  2011-01-28       Impact factor: 4.430

9.  Downregulation of transcription factor SOX2 in cancer stem cells suppresses growth and metastasis of lung cancer.

Authors:  R Xiang; D Liao; T Cheng; H Zhou; Q Shi; T S Chuang; D Markowitz; R A Reisfeld; Y Luo
Journal:  Br J Cancer       Date:  2011-04-05       Impact factor: 7.640

10.  NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.

Authors:  C R Jeter; B Liu; X Liu; X Chen; C Liu; T Calhoun-Davis; J Repass; H Zaehres; J J Shen; D G Tang
Journal:  Oncogene       Date:  2011-04-18       Impact factor: 9.867

View more
  57 in total

1.  MicroRNAs, a subpopulation of regulators, are involved in breast cancer progression through regulating breast cancer stem cells.

Authors:  Xuemei Fan; Wei Chen; Ziyi Fu; Lihua Zeng; Yongmei Yin; Hongyan Yuan
Journal:  Oncol Lett       Date:  2017-09-01       Impact factor: 2.967

2.  Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.

Authors:  Ramkishore Gernapudi; Yuan Yao; Yongshu Zhang; Benjamin Wolfson; Sanchita Roy; Nadire Duru; Gabriel Eades; Peixin Yang; Qun Zhou
Journal:  Breast Cancer Res Treat       Date:  2015-03-18       Impact factor: 4.872

3.  A High-Fat Diet Promotes Mammary Gland Myofibroblast Differentiation through MicroRNA 140 Downregulation.

Authors:  Benjamin Wolfson; Yongshu Zhang; Ramkishore Gernapudi; Nadire Duru; Yuan Yao; Pang-Kuo Lo; Qun Zhou
Journal:  Mol Cell Biol       Date:  2017-02-01       Impact factor: 4.272

4.  MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.

Authors:  Xiao Lu; Rui Liu; Meina Wang; Alagamuthu Karthick Kumar; Feiyan Pan; Lingfeng He; Zhigang Hu; Zhigang Guo
Journal:  Oncogene       Date:  2019-08-30       Impact factor: 9.867

5.  Identification of lncRNA TRPM2-AS/miR-140-3p/PYCR1 axis's proliferates and anti-apoptotic effect on breast cancer using co-expression network analysis.

Authors:  Tong Sun; Yan Song; Hong Yu; Xiao Luo
Journal:  Cancer Biol Ther       Date:  2019-02-27       Impact factor: 4.742

6.  NRF2/long noncoding RNA ROR signaling regulates mammary stem cell expansion and protects against estrogen genotoxicity.

Authors:  Yongshu Zhang; Jixiang Xia; Qinglin Li; Yuan Yao; Gabriel Eades; Ramkishore Gernapudi; Nadire Duru; Thomas W Kensler; Qun Zhou
Journal:  J Biol Chem       Date:  2014-09-17       Impact factor: 5.157

Review 7.  Sox2: regulation of expression and contribution to brain tumors.

Authors:  Sheila Mansouri; Romina Nejad; Merve Karabork; Can Ekinci; Ihsan Solaroglu; Kenneth D Aldape; Gelareh Zadeh
Journal:  CNS Oncol       Date:  2016-05-27

8.  Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide.

Authors:  Su-Hyeong Kim; Catherine H Kaschula; Nolan Priedigkeit; Adrian V Lee; Shivendra V Singh
Journal:  J Biol Chem       Date:  2016-04-29       Impact factor: 5.157

9.  NRF2/miR-140 signaling confers radioprotection to human lung fibroblasts.

Authors:  Nadire Duru; Ramkishore Gernapudi; Yongshu Zhang; Yuan Yao; Pang-Kuo Lo; Benjamin Wolfson; Qun Zhou
Journal:  Cancer Lett       Date:  2015-08-20       Impact factor: 8.679

10.  Epigenetic Regulation of miRNAs and Breast Cancer Stem Cells.

Authors:  Nadire Duru; Ramkishore Gernapudi; Gabriel Eades; Richard Eckert; Qun Zhou
Journal:  Curr Pharmacol Rep       Date:  2015-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.